Paratek Pharmaceuticals Logo
Paratek Pharmaceuticals Announces Appointment of Douglas Pagan as Chief Financial Officer
December 03, 2014 08:00 ET | Paratek Pharmaceuticals
BOSTON, Dec. 3, 2014 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced Douglas Pagán will join Paratek's executive leadership team as chief financial officer,...
Paratek Pharmaceuticals Logo
Paratek Pharmaceuticals Highlights Newly Expanded Board of Directors
November 06, 2014 08:00 ET | Paratek Pharmaceuticals
BOSTON, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) recently announced the members of its newly expanded board of directors. Michael F Bigham, Thomas J. Dietz, Ph.D,...
Paratek Pharmaceuticals Logo
Paratek Pharmaceuticals Strengthens Management Team
November 04, 2014 08:00 ET | Paratek Pharmaceuticals
BOSTON, Nov. 4, 2014 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced the addition of three new, experienced individuals to its management team. They bring significant...
Paratek Pharmaceuticals Logo
Paratek Pharmaceuticals Completes Merger With Transcept Pharmaceuticals
October 30, 2014 13:31 ET | Paratek Pharmaceuticals
BOSTON, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) and Transcept Pharmaceuticals, Inc. (Nasdaq:TSPT) (through October 30) today announced the two companies have...
Paratek Pharmaceuticals Logo
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
July 01, 2014 06:30 ET | Paratek Pharmaceuticals
BOSTON, July 1, 2014 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., today announced that Michael F. Bigham, Partner at Abingworth LLP, has been appointed as Chairman of the Board of Directors and...